Vagus Nerve Stimulation Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.ElectroCore raises $1.5m
ElectroCore raised $1.5 million in a new round of debt financing, according to an SEC filing posted today.
ElectroCore is developing a range of non-invasive vagus nerve stimulation for the treatment of a number of conditions in neurology, psychiatry, gastroenterology and other fields, according to the company’s website.
Initial focus for the company is a non-invasive, self-administered vagus nerve stimulation treatment for headaches. The nVNS procedure is designed to treat migraine and cluster headaches, and has CE Mark approval in the European Union.
Money in the round so far has come from a single anonymous investor, ...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation Pain Management electroCore Source Type: news
Noninvasive VNS Promising in Chronic Migraine Prevention Noninvasive VNS Promising in Chronic Migraine Prevention
Pilot results show a noninvasive vagus nerve stimulation device was safe and well tolerated, and it may reduce headache days in chronic migraine. < br / > < i > Medscape Medical News < /i > (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 22, 2016 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news
Your NEJM Group Today: Milk of Urate Bulla Images, Vagus Nerve Stimulation, Washington State FM Opportunity (FREE)
By the Editors
NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: Images in Clinical … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 19, 2016 Category: Primary Care Source Type: news
Vagus nerve stimulation may help reduce rheumatoid arthritis symptoms
Stephen FellerWASHINGTON, July 5 (UPI) -- Implanting a device to stimulate the vagus nerve helped rheumatoid arthritis patients improve significantly, according to a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 5, 2016 Category: Consumer Health News Source Type: news
Nerve stimulation device 'can offer relief from rheumatoid arthritis symptoms'
This study is interesting and shows promising results that explore the link between the nervous system and inflammation in rheumatoid arthritis. This link is significant, as it could indicate the potential for alternative treatments for inflammatory conditions. However, the sample size is small, so more research is needed into the long-term effects of this intervention."Rheumatoid arthritis is a painful and debilitating condition that has a huge impact on more than 400,000 people within the UK. We now understand far more about the process of inflammation, and this understanding has led to new and better forms of treat...
Source: Arthritis Research UK - July 4, 2016 Category: Rheumatology Source Type: news
Study shows vagus nerve stimulation significantly reduces rheumatoid arthritis symptoms
(Northwell Health) Clinical trial data published in the Proceedings of the National Academy of Sciences (PNAS) demonstrates stimulating the vagus nerve with an implantable bioelectronic device significantly improved measures of disease activity in patients with rheumatoid arthritis (RA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 4, 2016 Category: Global & Universal Source Type: news
SUDEP Rate Lower in Epilepsy Patients After VNSSUDEP Rate Lower in Epilepsy Patients After VNS
A new large observational study increases the power of previous studies by 100-fold and suggests patients with drug-resistant epilepsy treated with vagus nerve stimulation have a reduced risk of sudden death. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 30, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
NICE Provides Positive Guidance on electroCore's gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
BASKING RIDGE, New Jersey, April 1, 2016 -- (Healthcare Sales & Marketing Network) -- The UK's National Institute of Health and Care Excellence (NICE) has published guidance that electroCore's non-invasive vagus nerve stimulation treatment (gammaCore) for... Devices, Neurology, RegulatoryelectroCore, gammaCore, vagus nerve stimulation, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2016 Category: Pharmaceuticals Source Type: news
New non-invasive form of vagus nerve stimulation works to treat depression
Depression can be a devastating and unremitting problem. Researchers now report successful reduction of depressive symptoms in patients using a novel non-invasive method of vagus nerve stimulation, or VNS. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 4, 2016 Category: Science Source Type: news
Medtech approvals: FDA releases December 2015 PMAs
The Food & Drug Administration today released a list of pre-market approvals granted in December 2015:
Summary of PMA Originals & Supplements Approved
Originals: 2
Supplements: 81
Summary of PMA Originals Under Review
Total Under Review: 58
Total Active: 32
Total On Hold: 26
Summary of PMA Supplements Under Review
Total Under Review: 599
Total Active: 423
Total On Hold: 176
Summary of All PMA Submissions
Originals: 3
Supplements: 92
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 81
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 163.1
FDA Time: 140....
Source: Mass Device - February 2, 2016 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
Medtech approvals: FDA releases November 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in November 2015:
Summary of PMA Originals & Supplements Approved
Originals: 3
Supplements: 69
Summary of PMA Originals Under Review
Total Under Review: 57
Total Active: 30
Total On Hold: 27
Summary of PMA Supplements Under Review
Total Under Review: 583
Total Active: 433
Total On Hold: 150
Summary of All PMA Submissions
Originals: 4
Supplements: 75
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 69
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 193.4
FDA Time: 1...
Source: Mass Device - January 22, 2016 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
Vagus nerve stimulation shows progress in stroke patient recovery
Vagus nerve stimulation (VNS) technology could help improve the lives of hundreds of thousands of people who suffer weakness and paralysis caused by strokes, new research suggests. The study marks the first time that VNS has been tested in individuals recovering from stroke. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 9, 2015 Category: Science Source Type: news
Medtech approvals: FDA releases October 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in October 2015:
Summary of PMA Originals & Supplements Approved
Originals: 9
Supplements: 133
Summary of PMA Originals Under Review
Total Under Review: 58
Total Active: 32
Total On Hold: 26
Summary of PMA Supplements Under Review
Total Under Review: 597
Total Active: 433
Total On Hold: 164
Summary of All PMA Submissions
Originals: 7
Supplements: 74
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 133
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 161.5
FDA Time: ...
Source: Mass Device - December 4, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
UT Dallas researchers use vagus nerve stimulation outside the forebrain
(University of Texas at Dallas) Dr. Patrick Ganzer of the Texas Biomedical Device Center won a best paper award for work that uses vagus nerve stimulation paired with rehabilitation to enhance neuroplasticity. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 17, 2015 Category: Biology Source Type: news
NeuroSigma wins CE Mark for eTNS ADHD system
NeuroSigma Systems said today it won CE Mark approval in the European Union for its Monarch eTNS system to treat attention-deficit/hyperactivity disorder in adults and children 7 and older.
Los Angeles-based NeuroSigma said it is the 1st and only non-drug treatment for ADHD approved in the European Union.
“ADHD is estimated to affect up to 9.5% of school age children and 4.4% of adults, and many people have concerns about using stimulant medications. In research conducted at the University of California, Los Angeles, eTNS was well accepted by children and their parents, and produced significant improvements in th...
Source: Mass Device - November 17, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Neurological Regulatory/Compliance NeuroSigma Inc Source Type: news
